The Patent Finder
OS

The Ohio State University

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

78 patents currently held

63 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.

The next term ends in Jan 2027. from the record

Of the 63 now held by other companies, 33 name Ohio State Innovation Foundation as their current owner, and 30 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
29
Ending by 2030
Jan 2027
Next term end
67
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Inhibitors of PRMT5 and Methods of Their Use US 10,723,698
Granted 2020. Computed term ends 2034. A terminal disclaimer caps this term to an earlier patent's.
Ends Mar 2034 · Low confidence
Also notable
Methods of Treatment for Bacterial Infections US 11,191,773
Granted 2021. Computed term ends 2038.
Ends Jul 2038 · High confidence
Also notable
Methods for Diagnosing Colon Cancer Using Microrna Signatures US 9,017,940
The largest patent family in this portfolio, 25 related applications, renewed at 3 of 3 maintenance windows. Protection runs to 2027. A terminal disclaimer caps this term to an earlier patent's.
Ends Jan 2027 · Medium confidence

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 121 later US patents, top 5% of utility patents granted in 2012 in our data. Protection runs to 2027.
Ends Jan 2027 · High confidence
Also notable
Cited by 62 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2031. A terminal disclaimer caps this term to an earlier patent's.
Ends Nov 2031 · High confidence
Also notable
Cited by 29 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
now held by RTX Corporation
Ends May 2032 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 4 fees due Dec 2 to 23, 2026 · next Dec 2
  • 2 fees due Jan 9 to 14, 2027 · next Jan 9
  • 1 fee due Mar 15, 2027
    The maintenance fee for Catalysts for Use in Electrochemical Applications and Electrodes and Devices Using Same (US 9,136,542) comes due Mar 15, 2027. Unpaid by Sep 15, 2027, it lapses early.
  • 2 fees due Aug 2 to 23, 2027 · next Aug 2
  • 2 fees due Sep 8 to 15, 2027 · next Sep 8

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 21, 2026

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 7,473,028Method and Device for Investigation of Phase Transformations in Metals and Alloys
In force
 · High confidence
In forceHigh confidence
US 9,017,939Methods for Diagnosing Breast, Colon, Lung, Pancreatic and Prostate Cancer Using miR-21 and miR-17-5p
In force
 · Medium confidence
In forceMedium confidence
US 9,017,940Methods for Diagnosing Colon Cancer Using Microrna Signatures
In force
 · Medium confidence
In forceMedium confidence
US 9,051,618Methods for Diagnosing Lung Cancer Using MicroRNA Signatures
In force
 · High confidence
In forceHigh confidence
US 7,488,462Multi-Stage Catalyst Systems and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 7,630,598Apparatus and Method for Providing an Optical Cross-Connect
In force
 · High confidence
In forceHigh confidence
US 7,633,670Methods, Systems, and Devices for Steering Optical Beams
In force
 · High confidence
In forceHigh confidence
US 7,921,949All Wheel Drive Electrically-Variable Transmission
In force
 · High confidence
In forceHigh confidence
US D685,268Spray Device
In force
 · High confidence
In forceHigh confidence
US 9,023,598Methods for Diagnosing Pancreatic Cancer Using MIR-103-1, MIR-103-2, MIR-24-2 and MIR-107
In force
 · High confidence
In forceHigh confidence
10 of 78 patents shown.
Pro members see all 78.
Pro members: see all 78 patents
Also on record, not counted in the 78: 63 patents in force now held by others · 117 patents ended · 8 applications pending · 139 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited